Comparison between Agilus Diagnostics IPO and KSH International IPO.
Agilus Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while KSH International IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Agilus Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the KSH International IPO is up to ₹626.35 Cr. The final issue price of Agilus Diagnostics IPO is and of KSH International IPO is ₹384.00 per share.
| Agilus Diagnostics IPO | KSH International IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹365.00 per share | |
| Issue Price (Upper) | ₹384.00 per share | |
| Issue Price (Final) | ₹384.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 39 shares | |
| Fresh Issue Size | 0 shares | 1,09,37,500 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹420.00 Cr |
| OFS Issue Size | 1,42,33,964 shares | 53,73,803 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹206.35 Cr |
| Issue Size Total | 1,42,33,964 shares | 1,63,11,303 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹626.35 Cr |
Agilus Diagnostics IPO opens on , while KSH International IPO opens on Dec 16, 2025. The closing date of Agilus Diagnostics IPO and KSH International IPO is , and Dec 18, 2025, respectively.
| Agilus Diagnostics IPO | KSH International IPO | |
|---|---|---|
| Anchor Bid Date | Dec 15, 2025 | |
| Issue Open | Dec 16, 2025 | |
| Issue Close | Dec 18, 2025 | |
| Basis Of Allotment (Tentative) | Dec 19, 2025 | |
| Initiation of Refunds (Tentative) | Dec 22, 2025 | |
| Credit of Share (Tentative) | Dec 22, 2025 | |
| Listing date (Tentative) | Dec 23, 2025 | |
| Anchor Lockin End date 1 | Jan 17, 2026 | |
| Anchor Lockin End date 2 | Mar 18, 2026 |
Agilus Diagnostics IPO P/E ratio is , as compared to KSH International IPO P/E ratio of 32.09.
| Agilus Diagnostics IPO | KSH International IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)KSH International Ltd.'s revenue increased by 39% and profit after tax (PAT) rose by 82% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.68 | 98.4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2601.82 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.12% | 22.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.17% | 16.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.61% | 22.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Agilus Diagnostics IPO Retail Individual Investors (RII) are offered while in KSH International IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Agilus Diagnostics IPO and 28,44,375 shares in KSH International IPO.
| Agilus Diagnostics IPO | KSH International IPO | |
|---|---|---|
| Anchor Investor Reservation | 55,46,874 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 28,44,375 shares | |
| NII | 25,17,376 shares | |
| RII | 58,73,876 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 1,67,82,501 shares |
Agilus Diagnostics IPO subscribed in total, whereas KSH International IPO subscribed 0.87x.
| Agilus Diagnostics IPO | KSH International IPO | |
|---|---|---|
| QIB (times) | 1.12x | |
| NII (times) | 0.44x | |
| Big NII (times) | 0.26x | |
| Small NII (times) | 0.80x | |
| RII (times) | 0.91x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 0.87x |
